We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Stock

Invest in or calculate the value of your shares in Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) or other pre-IPO companies through EquityZen's platform.

Get Started

Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Stock

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

About Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Stock

Founded

2017

Headquarters

Berwyn, PA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our dedication to addressing drug-resistant epilepsy and rare diseases. With a focus on optimizing non-addictive medications, our drug delivery platforms target unmet global needs in markets such as Post Operative Pain, Severe Pain, Post Cancer Pain, and Rare Pediatric Epilepsy, including orphan diseases like Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome. Virpax is at the forefront of providing differentiated solutions for these diverse healthcare challenges.

Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Press Mentions

Stay in the know about the latest news on Virpax Pharmaceuticals Inc. (Nasdaq:VRPX)

Locked Features

Join now and verify your accreditation status to gain access to:

  • Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) current valuation
  • Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) stock price
  • Available deals in Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Stock

How to invest in Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) stock?

Accredited investors can buy pre-IPO stock in companies like Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) through EquityZen funds. These investments are made available by existing Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) stock?

Shareholders can sell their Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."